Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161797-99-5 Febuxostat Nadiif Dhexdhexaad ah>99.0% Warshada
Soo-saarka Kiimikada Ruifu Febuxostat Dhexdhexaadiyaha La Xiriira:
Febuxostat CAS 144060-53-7
Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS 25984-63-8
Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
Ethyl 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-01-2
Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-03-4
Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161797-99-5
Magaca Kiimikada | Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate |
La mid ah | Febuxostat Dhexdhexaad |
Lambarka CAS | 161797-99-5 |
Lambarka CAT | RF-PI1122 |
Heerka Saamiyada | Kaydka dhexdiisa, Awoodda Wax-soo-saarka 100 Tan/Sannad |
Qaanuunka molecular | C13H13NO3S |
Miisaanka Molecular | 263.31 |
Meesha dhalaalaysa | 180℃ |
Summada | Kiimikada Ruifu |
Shayga | Tilmaamaha |
Muuqashada | Jaalle fudud ilaa budo cad ka baxsan |
Aqoonsiga | Waxaa qoray HPLC;By HNMR |
Khasaare xagga qalajinta | <0.50% |
Hadhaaga Ighition | <0.30% |
Xumaanta Keliya | <0.50% |
Wadarta wasakhda | <1.00% |
Daahirnimada / Habka Falanqaynta | >99.0% (waxaa qoray HPLC) |
Heerka Imtixaanka | Heerka Ganacsiga |
Isticmaalka | Dhexdhexaadiyaha Febuxostat (CAS: 144060-53-7) |
Xidhmada: Dhalo, bacda bireed aluminium, 25kg / Durbaan kartoonada, ama sida waafaqsan shuruudaha macmiilka
Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka iyo qoyaanka
Ethyl 2- (4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylate (CAS: 161797-99-5) waxaa loo isticmaalaa isku-dhafka Febuxostat (CAS: 144060-53-7), xanthine oxidase / xanthine dehydrogenase inhibitor.Waxaa loo isticmaalaa daawaynta hyperuricemia iyo gout raaga.40-120 mg/maalintii febuxostat ayaa la xaqiijiyay inay wax ku ool u tahay hoos u dhigista heerarka serum urate marka la maamulo si loo maareeyo hyperuricemia ee bukaanka qaba gout.Fabuxostat waxaa helay Teijin Pharmaceuticals oo shati u siisay TAP Pharmaceuticals (oo hadda qayb ka ah Takeda Pharmaceuticals) waxaana laga oggolaaday Maraykanka daawaynta hyperuricemia ee bukaannada qaba gout.